"Trade creep" and implications of the Transatlantic Trade and Investment Partnership Agreement for the United Kingdom National Health Service

Meri Koivusalo, Jonathan Tritter

Research output: Contribution to journalArticle

Abstract

The ambitious and comprehensive Transatlantic Trade and Investment Partnership Agreement (TTIP/TAFTA) agreement between the European Union and United States is now being negotiated and may have far-reaching consequences for health services. The agreement extends to government procurement, investment, and further regulatory cooperation. In this article, we focus on the United Kingdom National Health Service and how these negotiations can limit policy space to change policies and to regulate in relation to health services, pharmaceuticals, medical devices, and health industries. The negotiation of TTIP/TAFTA has the potential to "harmonize" more corporate-friendly regulation, resulting in higher costs and loss of policy space, an example of "trade creep" that potentially compromises health equity, public health, and safety concerns across the Atlantic.
Original languageEnglish
Pages (from-to)93-111
Number of pages19
JournalInternational Journal of Health Services
Volume44
Issue number1
DOIs
Publication statusPublished - 31 Jan 2014

Fingerprint

National Health Programs
Negotiating
Health Services
European Union
Industry
Public Health
Safety
Costs and Cost Analysis
Equipment and Supplies
Health
Pharmaceutical Preparations
United Kingdom

Cite this

@article{d3976be1ff194dcbb8c0ddca9cd40ec8,
title = "{"}Trade creep{"} and implications of the Transatlantic Trade and Investment Partnership Agreement for the United Kingdom National Health Service",
abstract = "The ambitious and comprehensive Transatlantic Trade and Investment Partnership Agreement (TTIP/TAFTA) agreement between the European Union and United States is now being negotiated and may have far-reaching consequences for health services. The agreement extends to government procurement, investment, and further regulatory cooperation. In this article, we focus on the United Kingdom National Health Service and how these negotiations can limit policy space to change policies and to regulate in relation to health services, pharmaceuticals, medical devices, and health industries. The negotiation of TTIP/TAFTA has the potential to {"}harmonize{"} more corporate-friendly regulation, resulting in higher costs and loss of policy space, an example of {"}trade creep{"} that potentially compromises health equity, public health, and safety concerns across the Atlantic.",
author = "Meri Koivusalo and Jonathan Tritter",
year = "2014",
month = "1",
day = "31",
doi = "10.2190/HS.44.1.f",
language = "English",
volume = "44",
pages = "93--111",
journal = "International Journal of Health Services",
issn = "0020-7314",
publisher = "Baywood Publishing Co. Inc.",
number = "1",

}

TY - JOUR

T1 - "Trade creep" and implications of the Transatlantic Trade and Investment Partnership Agreement for the United Kingdom National Health Service

AU - Koivusalo, Meri

AU - Tritter, Jonathan

PY - 2014/1/31

Y1 - 2014/1/31

N2 - The ambitious and comprehensive Transatlantic Trade and Investment Partnership Agreement (TTIP/TAFTA) agreement between the European Union and United States is now being negotiated and may have far-reaching consequences for health services. The agreement extends to government procurement, investment, and further regulatory cooperation. In this article, we focus on the United Kingdom National Health Service and how these negotiations can limit policy space to change policies and to regulate in relation to health services, pharmaceuticals, medical devices, and health industries. The negotiation of TTIP/TAFTA has the potential to "harmonize" more corporate-friendly regulation, resulting in higher costs and loss of policy space, an example of "trade creep" that potentially compromises health equity, public health, and safety concerns across the Atlantic.

AB - The ambitious and comprehensive Transatlantic Trade and Investment Partnership Agreement (TTIP/TAFTA) agreement between the European Union and United States is now being negotiated and may have far-reaching consequences for health services. The agreement extends to government procurement, investment, and further regulatory cooperation. In this article, we focus on the United Kingdom National Health Service and how these negotiations can limit policy space to change policies and to regulate in relation to health services, pharmaceuticals, medical devices, and health industries. The negotiation of TTIP/TAFTA has the potential to "harmonize" more corporate-friendly regulation, resulting in higher costs and loss of policy space, an example of "trade creep" that potentially compromises health equity, public health, and safety concerns across the Atlantic.

UR - http://joh.sagepub.com/content/44/1/93

U2 - 10.2190/HS.44.1.f

DO - 10.2190/HS.44.1.f

M3 - Article

VL - 44

SP - 93

EP - 111

JO - International Journal of Health Services

JF - International Journal of Health Services

SN - 0020-7314

IS - 1

ER -